|
KATNA1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.57079999802457E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.02109999741995E-08 |
| Normal-vs-Stage2 |
1.89704999999929E-05 |
| Normal-vs-Stage3 |
8.194000E-02 |
| Normal-vs-Stage4 |
2.831000E-01 |
| Stage1-vs-Stage2 |
8.319600E-01 |
| Stage1-vs-Stage3 |
1.847990E-01 |
| Stage1-vs-Stage4 |
3.772200E-01 |
| Stage2-vs-Stage3 |
2.248200E-01 |
| Stage2-vs-Stage4 |
4.204400E-01 |
| Stage3-vs-Stage4 |
9.966400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.84549999516071E-08 |
| Normal-vs-AfricanAmerican |
6.962300E-03 |
| Normal-vs-Asian |
2.270400E-01 |
| Caucasian-vs-AfricanAmerican |
1.834170E-01 |
| Caucasian-vs-Asian |
9.597400E-01 |
| AfricanAmerican-vs-Asian |
7.036200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.49370010488803E-10 |
| Normal-vs-Female |
1.066750E-01 |
| Male-vs-Female |
1.774270E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.236900E-04 |
| Normal-vs-Extreme_Weight |
2.83350010121808E-11 |
| Normal-vs-Obese |
2.158800E-03 |
| Normal-vs-Extreme_Obese |
1.658990E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.453570E-01 |
| Normal_Weight-vs-Obese |
3.780200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.350800E-01 |
| Extreme_Weight-vs-Obese |
3.278100E-03 |
| Extreme_Weight-vs-Extreme_Obese |
3.869600E-01 |
| Obese-vs-Extreme_Obese |
7.721400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.267190E-01 |
| Normal-vs-Age(41-60Yrs) |
1.214070E-04 |
| Normal-vs-Age(61-80Yrs) |
3.25329999606438E-08 |
| Normal-vs-Age(81-100Yrs) |
6.155700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.692400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.803440E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.828240E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.167970E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.709400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.232800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.2425999945952E-08 |
| Normal-VS-Type2 PRCC |
3.379600E-03 |
| Normal-VS-KIRP CIMP |
3.378600E-01 |
| Normal-VS-Unclassified PRCC |
3.695400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.442200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.298200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.285200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.617000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.987000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.089200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.0994000000375E-06 |
| Normal-vs-N1 |
6.702000E-01 |
| Normal-vs-N2 |
2.42039999999166E-05 |
| N0-vs-N1 |
9.022000E-03 |
| N0-vs-N2 |
2.246600E-01 |
| N1-vs-N2 |
6.347500E-02 |
|
|
